# Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia

> **NCT04661644** · PHASE1,PHASE2 · COMPLETED · sponsor: **S.Biomedics Co., Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **BIOLOGICAL:** Clusters of adipose-derived mesenchymal stem cells (Dose: 1 x 10^7 cells/1 mL/vial)
- **BIOLOGICAL:** Clusters of adipose-derived mesenchymal stem cells (Dose: 1 x 10^8 cells/1 mL/vial)

## Key facts

- **NCT ID:** NCT04661644
- **Lead sponsor:** S.Biomedics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-04
- **Primary completion:** 2024-04-22
- **Final completion:** 2024-07-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04661644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04661644, "Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04661644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*